ITL is an innovative medical technology company (89 patents 2016), supplier and strategic partner that provides products and solutions to healthcare markets and empowers individual health management. We set standards for essential products through innovation and by leveraging market intelligence to optimise end-user safety and efficiency, and effectively meet stringent clinical demands and regulatory requirements worldwide.

MyHealthTest participates in external quality assurance programs — the RCPA QAP (Royal College of Pathologists of Australasia Quality Assurance Program) and international RIQAS (Randox International Quality Assessment Scheme).

Our worldwide footprint serves blood banks, hospitals and health systems, laboratories, and veterinary medicine and animal production facilities in more than 55 countries throughout North America, South America, Europe, Asia, the Middle East, Australia, and Malaysia.


Our mission is to provide innovative products and solutions to healthcare markets worldwide as well as empower individuals to take control of their own health management through better access and information.